Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential

References

• Barth RF, Mi P, Yang W. 2018a. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun. 38(1):35.
   Web of Science ®Google Scholar
• Barth RF, Zhang Z, Liu T. 2018b. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Commun. 38(1):36.
   Web of Science ®Google Scholar
• Brown JM. 1979. Evidence of acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. BJR. 52(620):650–656.
   Google Scholar
• Cairns RA, Kalliomaki T, Hill RP. 2001. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 61(24):8903–8908.
   PubMed Web of Science ®Google Scholar
• Chaplin DJ, Horsman MR, Trotter MJ. 1990. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst. 82(8):672–676.
   PubMedGoogle Scholar
• Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd. 2003. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat. 2(5):355–375.
   PubMed Web of Science ®Google Scholar
• De Jaeger K, Kavanagh M-C, Hill RP. 2001. Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer. 84(9):1280–1285.
   PubMed Web of Science ®Google Scholar
• Duan X, Zhang H, Liu B, Li XD, Gao QX, Wu ZH. 2008. Apoptosis of murine melanoma cells induced by heavy-ion radiation combined with Tp53 gene transfer. Int J Radiat Biol. 84(3):211–217.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Lee CT, Ashcraft KA. 2016. The future of biology in driving the field of hyperthermia. Int J Hyperthermia. 32(1):4–13.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. 2003. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 3(6):453–845.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Okajima K, Ogawa A, Song CW. 1999. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. Int J Radiat Biol. 75(10):1299–1306.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kanda K. 1983. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry. Nucl Instrum Methods. 204(2–3):525–531.
   Web of Science ®Google Scholar
• Kobayashi T, Sakurai Y, Kanda K, Fujita Y, Ono K. 2000. The remodeling and basic characteristics of the heavy water neutron irradiation facility of the Kyoto University Research Reactor, mainly for neutron capture therapy. Nucl Tech. 131(3):354–378.
   Web of Science ®Google Scholar
• Masunaga S, Ono K, Suzuki M, Nishimura Y, Hiraoka M, Kinashi Y, Takagaki M, Akaboshi M. 1997. Alteration of the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. Int J Hyperthermia. 13(4):401–411.
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M. 2001a. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Int J Radiat Oncol Biol Phys. 51(3):828–839.
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H. 2001b. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells. Jpn J Cancer Res. 92(9):996–1007.
   PubMedGoogle Scholar
• Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. 2005. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Int J Hyperthermia. 21(4):305–318.
   PubMed Web of Science ®Google Scholar
• Masunaga S, Nishimura Y, Hiraoka M, Abe M, Takahashi M, Ono K. 2007. Efficacy of mild temperature hyperthermia in combined treatments for cancer therapy. Thermal Med. 23(3):103–112.
   Google Scholar
• Masunaga S, Matsumoto Y, Hirayama R, Kashino G, Tanaka H, Suzuki M, Kinashi Y, Liu Y, Ando K, Ono K. 2009. Significance of hypoxia manipulation in solid tumors in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells. Clin Exp Metastasis. 26(7):693–700.
   PubMed Web of Science ®Google Scholar
• Masunaga S. 2016. Tumor microenvironment and hyperthermia. In: Kokura S, Yoshikawa T, Ohnishi T, editors. Hyperthermic oncology from bench to bedside. Singapore: Springer; p. 151–169.
   Google Scholar
• Mirzaei HR, Sahebkar A, Salehi R, Nahand JS, Karimi E, Jaafari MR, Mirzaei H. 2016. Boron neutron capture therapy: moving toward targeted cancer therapy. J Can Res Ther. 12(2):520–525.
   PubMed Web of Science ®Google Scholar
• Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, et al. 2005. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg. 103(6):1000–1009.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y. 1990. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res. 122(2):161–167.
   PubMed Web of Science ®Google Scholar
• Moller MG, Lewis JM, Dessureault S, Zager JS. 2008. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Int J Hyperthermia. 24(3):275–289.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Galappathi K, Mathiesen B, Ruud E-B. 2007. Fluctuating and diffusion-limited hypoxia in hypoxiainduced metastasis. Clin Cancer Res. 13(7):1971–1978.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kobayashi T. 2000. Characteristics of the KUR Heavy Water Neutron Irradiation Facility as a neutron irradiation field with variable energy spectra. Nucl Instr Meth A. 453(3):569–596.
   Web of Science ®Google Scholar
• Soloway AH, Hatanaka H, Davis MA. 1967. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J Med Chem. 10(4):714–717.
   PubMed Web of Science ®Google Scholar
• Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Parry Howells G, Tipton I. 1975. Gross and elemental content of reference man. In: Snyder WS, editor. Report of the task group on reference man. Oxford, UK: Pergamon Press; p. 273–324.
   Google Scholar
• Van der Kogel AJ, Joiner MC 2019. The dose-rate effect. In: Joiner MC, van der Kogel AJ, editors. Basic clinical radiobiology. 5th ed. Boca Raton, FL: CRC Press; p. 143–151.
   Google Scholar
• Vaupel PW, Kelleher DK. 2010. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: heterogeneity is the key issue. Int J Hyperthermia. 26(3):211–223.
   PubMed Web of Science ®Google Scholar
• Wongthai P, Hagiwara K, Miyoshi Y, Wiriyasermkul P, Wei L, Ohgaki R, Kato I, Hamase K, Nagamori S, Kanai Y. 2015. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Cancer Sci. 106(3):279–286.
   PubMed Web of Science ®Google Scholar